⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AVLN News
Avalyn Pharma Inc. Common Stock
Avalyn Announces Multiple Presentations at the European Respiratory Society International Congress 2026
globenewswire.com
AVLN
Form 8-K
sec.gov
AVLN
Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights
globenewswire.com
AVLN
Form 8-K
sec.gov
AVLN
Form 8-K
sec.gov
AVLN
Avalyn Completes Target Enrollment in Phase 2b MIST Trial of AP01 (Inhaled Pirfenidone) for Patients with Progressive Pulmonary Fibrosis
globenewswire.com
AVLN
Form 8-K
sec.gov
AVLN
Avalyn Reports First Quarter 2026 Financial Results and Recent Business Highlights
globenewswire.com
AVLN
Avalyn to Participate in the Jefferies Global Healthcare Conference
globenewswire.com
AVLN
Avalyn Announces Additional Long-term Data on AP01, Inhaled Pirfenidone, for the Treatment of Pulmonary Fibrosis to be Presented at the European Alliance of Associations for Rheumatology 2026
globenewswire.com
AVLN